Stoke Therapeutics Inc (STOK)

SG&A Expenses

$80.52M

TTM · Period ending: · USD

STOK logo

STOK SG&A Expenses

Latest reported$80.52M
STOK TTM SG&A Expenses ($4.41M → $80.52M)
High-resolution chart · PNG

STOK sg&a expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Stoke Therapeutics Inc SG&A Expenses — Trailing twelve months (TTM) (USD)
Period endingSG&A Expenses (USD)
80,523,000
71,212,000
65,891,000
58,239,000
55,451,000
52,664,000
47,681,000
44,856,000
41,872,000
39,071,000
39,062,000
37,883,000
37,583,000
37,487,000
36,935,000
36,819,000
35,735,999
34,091,999
31,896,999
28,854,999
26,132,000
23,242,000
20,848,000
19,145,000
16,867,000
14,245,000
11,914,000
9,473,000
7,239,000
5,939,000
4,410,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.